Novo Nordisk Pharmaceutical Industries, Lp drugs

3 results

  • ozempic - semaglutide injection, solution

    (Semaglutide)
    Novo Nordisk Pharmaceutical Industries, Lp
    Ozempic is used alongside diet and exercise to improve blood sugar in adults with type 2 diabetes. It also reduces the risk of serious cardiovascular events in those with established heart disease, and lowers the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.
    Medication Details
    Drug Interactions

  • saxenda - liraglutide injection, solution

    (Liraglutide)
    Novo Nordisk Pharmaceutical Industries, Lp
    Saxenda (liraglutide) is indicated with reduced-calorie diet and exercise for long-term weight management in adults and pediatric patients 12+ years with obesity (weight >60 kg), and in adults with overweight and at least one weight-related comorbidity.
    Medication Details
    Drug Interactions

  • wegovy - semaglutide injection, solution

    (Semaglutide)
    Novo Nordisk Pharmaceutical Industries, Lp
    Wegovy reduces risk of major cardiovascular events in adults with established CV disease and obesity or overweight. It reduces excess body weight long term in adults and patients aged 12 and older with obesity or overweight with comorbidities, and treats MASH with moderate to advanced liver fibrosis in adults.
    Medication Details
    Drug Interactions